Briefing: Psychedelic Biotechs Under Scrutiny for YouTube Promotions

Increased regulatory scrutiny on psychedelic biotech companies.

Biogen and Eli Lilly are actively pursuing acquisitions.

Doctors Without Borders raises concerns about Gilead's practices.